Zygmunciak, P.; Dancewicz, H.; Stróżna, K.; Błażowska, O.; Bieliński, K.; Robak, T.; Puła, B.
Double Strike in Chronic Lymphocytic Leukemia—The Combination of BTK and BCL2 Inhibitors in Actual and Future Clinical Practice. Int. J. Mol. Sci. 2025, 26, 3193.
https://doi.org/10.3390/ijms26073193
AMA Style
Zygmunciak P, Dancewicz H, Stróżna K, Błażowska O, Bieliński K, Robak T, Puła B.
Double Strike in Chronic Lymphocytic Leukemia—The Combination of BTK and BCL2 Inhibitors in Actual and Future Clinical Practice. International Journal of Molecular Sciences. 2025; 26(7):3193.
https://doi.org/10.3390/ijms26073193
Chicago/Turabian Style
Zygmunciak, Przemyslaw, Hanna Dancewicz, Katarzyna Stróżna, Olga Błażowska, Krzysztof Bieliński, Tadeusz Robak, and Bartosz Puła.
2025. "Double Strike in Chronic Lymphocytic Leukemia—The Combination of BTK and BCL2 Inhibitors in Actual and Future Clinical Practice" International Journal of Molecular Sciences 26, no. 7: 3193.
https://doi.org/10.3390/ijms26073193
APA Style
Zygmunciak, P., Dancewicz, H., Stróżna, K., Błażowska, O., Bieliński, K., Robak, T., & Puła, B.
(2025). Double Strike in Chronic Lymphocytic Leukemia—The Combination of BTK and BCL2 Inhibitors in Actual and Future Clinical Practice. International Journal of Molecular Sciences, 26(7), 3193.
https://doi.org/10.3390/ijms26073193